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THE TIME FOR SCREENING LIMITS TO 
GUARD AGAINST ENVIRONMENTAL 
TRANSFER IS NOW
By Clara Fenger, DVM, PhD, DACVIM; Thomas Tobin, 
MRCVS, PhD, DABT; Maria Catignani; and Theodore Shults
ecreational drug use and the opiate epidemic have 
taken a great toll on the human population of the 
United States and beyond. Year over year, deaths from 
synthetic opioids—of which fentanyl ranks as the most 
prevalent—have skyrocketed, reaching 29,406 in 2017. 
Environmental transfer of drugs of human addiction to horses is nothing 
new. Cocaine and its primary metabolite, benzoylecgonine, have long been 
identified as environmental substances in post-race samples, and many 
jurisdictions have screening limits in place as a result. More recently, 
methamphetamine has begun to show up in post-race samples, reflecting 
the increasing addiction problem associated with this drug. In recognition 
of this growing problem, the National HBPA and North American Associa-
tion of Racetrack Veterinarians made a Model Rule recommendation to the 
Association of Racing Commissioners International for screening limits for 
substances of human addiction in racing horses. 
Fentanyl at Penn National
With fentanyl becoming the primary synthetic opioid implicated in 
overdose deaths, it should come as no surprise that trace environmental 
identifications should start to turn up in horse racing. Fortunately, this 
identification occurred in Pennsylvania, where rational heads prevail on 
the Pennsylvania Horse Racing Commission, and trace-level detections of 
environmental substances are seen as mitigating circumstances.
There is an evolving recognition of the arbitrary, capricious and totally 
antiquated status of “zero tolerance” when it comes to trace-level detec-
tions of environmental substances. In June 2018, a trace-level fentanyl 
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A FENTANYL POSITIVE AT PENN NATIONAL WAS ATTRIBUTED BY THE 
STEWARDS TO LIKELY HAVE BEEN CAUSED BY A DRUG-USING GROOM,  
AND HUMAN-TO-EQUINE TRANSFER IS ALSO A CONCERN AT TRACKS LIKE
KEENELAND (ABOVE) THAT ALLOW THE GENERAL PUBLIC TO VISIT THE 
BACKSIDE WITHOUT A RACING LICENSE.  
identification in a post-race urine sample collected from the horse Kion at Penn 
National Race Course was listed as positive. The stewards, strictly following the 
rules of racing, found the trainer, Guadalupe Preciado, in violation of the Penn-
sylvania medication rules but decided that “due to mitigating circumstances, 
there will be no further action on this drug positive.”
Reviewing this fentanyl identification, the stewards stated: “The drug 
positive probably occurred due to contamination of the horse Kion by stable em-
ployee Jeffrey Harris. Jeffrey Harris was the groom for Kion and was responsible 
for escorting the horse to the paddock and to the test barn following race 7 on 
June 23, 2018. Jeffrey Harris was interviewed by the Pennsylvania Horse Racing 
Commission investigators, and his dormitory room was searched at Parx. The 
result of the search and interview was that various drug paraphernalia was 
found in his room and Jeffrey Harris’ admission that he has a very serious drug 
dependency, and he was admitted to a drug rehabilitation center. There also has 
been an ongoing issue with this particular drug in the Philadelphia area.”
Fentanyl has a number of characteristics that make it a widely available 
and used street substance. The synthesis of fentanyl is, for a chemist, relatively 
straightforward, yielding an opiate about 100 times more potent than morphine 
or heroin. Because fentanyl is relatively easy to synthesize and small amounts, 
by weight, are very effective pharmacologically, the drug can be used to “cut,” 
or more likely to “enhance,” other street medications. The end result is wide 
availability and distribution of fentanyl and thus its random presence in the 
environment. 
Bringing this point home, there have been numerous stories in the news 
recently about major fentanyl busts, including a Customs Border Patrol seizure 
of about 100 pounds of fentanyl in July. This fentanyl shipment, identified by a 
drug-sniffing dog, was hidden in a shipment of iron oxide coming into the port 
of Philadelphia from China, reportedly a not-unusual source of fentanyl. News 
articles noted the danger to the sniffing dog of exposure to fentanyl because the 
drug is very easily and effectively absorbed transdermally and by inhalation. 
As well as being widely available, fentanyl is a poster-child for inadver-
tent transfer from a human user to a horse. The transdermal bioavailability of 
fentanyl is 92 percent, an unusually effective transfer, meaning that more than 
90 percent of an amount inadvertently contacted by the skin can be directly 
absorbed through the skin, and virtually the same fractional absorption occurs 
by inhalation. This means that, like the drug-sniffing dog, the horse only has 
to come into brief contact with a user for a transfer to occur, fully consistent 
with the recently increased numbers of trace-level identifications of fentanyl in 
Pennsylvania racing. 
The high sensitivity of modern equine drug testing has also contributed 
to the rise of these trace-level identifications. We understand that at least one 
fentanyl identification in Pennsylvania racing has been in the order of 300 
femtograms/ml in plasma, to date the lowest concentration identification of 
a medication in horse racing anywhere in the world that we are aware of. To 
put this concentration in perspective, one nanogram/ml is one part per billion, 
or one second in your life when you are 32 years old; one picogram/ml is one 
second in your life when you are 32,000 years old; and one femtogram/ml is one 
second in your life when you are a rather mature 32 million (yes, 32,000,000) 
years old. When substances are identified at femtogram/ml concentrations, or 
parts per quadrillion, such a substance is clearly present at levels in “Trace”—
with a capital T—concentrations. 
So, long story short, equine drug testing, the most sensitive routine drug 
testing on earth, is now picking up parts per quadrillion trace levels of fentanyl 
in equine blood and urine samples. These traces of fentanyl transfer randomly 
from individuals in the environment of the horse, are absorbed transdermally 
and are readily detected in post-race blood and urine samples. The Pennsylva-
nia stewards are to be congratulated on recognizing the fact that these identifi-
cations are, in terms of racing regulation, non-events, and as such the stewards 
correctly declined to take any further action on this positive identification.
Fentanyl in West Virginia
Similarly, the stewards at Charles Town Races in West Virginia recently 
ruled on another trace-level fentanyl identification, finding the trainer innocent 
and declining to penalize the trainer with either days or Multiple Medication 
Violation penalty points, although they did redistribute the purse. This was not 
as clear a statement of regulatory irrelevance of these trace-level identifications 
as was made in Pennsylvania, but it was at least a significant move in the right 
direction.
Another recent environmental transfer case in Charles Town racing involved 
identification of the human prescription medication gabapentin in blood and 
urine samples. Once the trainer was notified, he went back and checked his 
employees, at which point he discovered that one of his grooms was prescribed 
2,000 mg/day of gabapentin to treat his diabetic neuropathy. The stewards 
interpreted this information as mitigating circumstances and, as in the fentanyl 
matter, issued no fine or penalty other than loss of purse. Again, the stewards 
moved in the right direction in recognizing the innocent and inadvertent nature 
of these environmentally driven identifications, in this case associated with a 
human prescription medication.
These matters identify the reality of inadvertent transfer of substances 
from members of a trainer’s staff to horses in their care. The next question to 
be addressed is, if a substance readily transfers dermally like fentanyl, what is 
the probability of transfer of a substance of concern from, let us say, a starting 
gate crew member to a horse in the starting gate? To answer this question, we 
should first look to see if there is compelling evidence of the use of substances 
of concern by starting gate crew members.
Environmental Transfer from  
Assistant Starters?
On May 20, 2017, a horse named Carson’s Storm finished first in the eighth 
race at Canterbury Park in Minnesota and was blood and urine tested. The horse 
tested positive for methamphetamine, in the order of 150 pg/ml in blood and 
5 ng/ml in urine. Those concentrations are entirely consistent with inadvertent 
environmental exposure and are of no pharmacological significance. Reviewing 
the circumstances of this case, the attorney involved asked his expert whether 
transfer of methamphetamine could occur via dermal transfer from starting 
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reported in Carson’s Storm, to which the expert answered yes. 
What is particularly interesting about this Minnesota case is that from a 
review of contemporary rulings of Minnesota Racing Commission stewards, it 
appears that more than one member of the Canterbury Park starting gate crew 
was associated with or was a user of methamphetamine. Given this circumstance, 
the question put to his expert by the attorney concerned the likelihood of transfer 
of methamphetamine from a starting gate crew member to Carson’s Storm, at the 
levels reportedly identified in the horse. Reviewing the data and in agreement with 
the expert in this case, the answer has to be yes, and that transfer of sufficient 
methamphetamine to give rise to the concentrations identified in Carson’s Storm 
could indeed have occurred in the starting gate. The second point of concern is 
that the concentrations identified in Carson’s Storm are widely considered to be 
pharmacologically insignificant and as such of no regulatory or forensic signifi-
cance. The concentrations were also well below a published cut-off for environ-
mental exposure to methamphetamine in racing horses.
The Solution: Due Process
The final question then is how can trainers and indeed the industry itself 
protect against inadvertent environmental exposure to trace levels of prescrip-
tion and recreational substances? 
Moving away from the unsustainable concept of zero tolerance is the first 
step in protecting the due process rights of horsemen. Investigations into 
medication positives should include all aspects that may provide exculpatory 
evidence for the trainer. The first area of concern is the need to correctly identify 
the substance present in the sample and the concentrations present and also 
any metabolites present in each portion of the analytical sample, which usually 
consists of both blood and urine. In the data available to us in the case of the 
horse Kion in Pennsylvania, we do not know whether the detection was in blood 
or urine or both, and we also do not know the concentrations detected and 
whether the expected metabolites were present in the sample. Where metab-
olites are not identified, the timing of the introduction of the substance in the 
sample cannot be surmised.
In the methamphetamine identification in the Carson’s Storm case, the 
specific isomer of methamphetamine present was not identified in the initial 
$95 A sample analysis performed by the racing commission. The penalty for 
l-methamphetamine differs from d-methamphetamine and, therefore, should 
critically have been part of that initial confirmation. However, the racing com-
mission apparently did require that the much more expensive B split sample 
analysis specifically identify the methamphetamine isomer present, which 
turned out to be the more pharmacologically active and higher penalty d-isomer 
of methamphetamine. This created an unusual circumstance whereby the 
defendant was paying in the split sample analysis to generate evidence against 
himself, presumably in conflict with his right to remain silent. 
A critical piece of the epidemiological forensic 
evidence for horsemen is an estimate of the concentra-
tions of the environmental substance and its metab-
olites. Because these identifications are of environ-
mental origin, the only relevant data is the actual field 
data, so one must then “walk backward” to determine 
the source of the identifications and their forensic 
relevance. Additionally, environmental exposures will 
most likely vary from environment to environment and 
also from season to season, so concentration data is 
absolutely critical. Many substances in the environment 
differ from one season to the next or even depending on 
the day of the week. One study showed five times higher 
levels of NyQuil (which contains dextrorphan) in the 
winter months than the summer months in the South Platte River in Colorado, 
presumably reflecting the higher usage of cough suppressants by Denver residents 
during “flu season.” Another study showed higher levels of MDMA or “ecstasy” in 
wastewater facilities in Ontario after the weekend.
Concentration data in blood and urine and metabolite data also can be 
helpful in directing attention to the actual time of exposure. Detection in blood 
only, with no detection in urine or no metabolites in urine, obviously indicates 
more recent exposure to a substance. This is important because we cannot rule 
out inadvertent exposure from the starting gate crew as possible in Minnesota 
and elsewhere or even in the test barn. The authors are aware of instances of 
test barn personnel being prescribed fentanyl patches and paddock judges 
taking tramadol, suggesting test barn and other racetrack personnel may serve 
as the source of either equine exposure or, in at least one case, contamination 
of a collection sample with cocaine.
Another matter arises concerning the testing of personnel. Where possible, 
the rule in personnel testing is to include hair testing as a prerequisite for 
employment. Drug addiction is a chronic behavior, and blood and urine testing 
only reflect recent exposure. Hair testing is longitudinal and tells you what 
the individual has been exposed to/consuming/recreating with/prescribed 
for a matter of weeks prior to testing. Standard human urine tests have two 
significant problems. First, they only detect recent drug use, and second, they 
are also easily circumvented by the individual being tested. In fact, our human 
forensic colleagues tell us that the “railroad rule” is to test the hair of potential 
employees at the time of application. If the potential employees pass the hair 
test, employers can proceed with confidence that the individuals hired are by 
and large members of the distinct subculture of non-recreational drug users. 
Conclusion
With the advent of ever-increasing sensitivity of equine drug testing, there 
is an urgent need for industry-wide communication of regulatory experience and 
regulatory cut-offs in the area of random environmental exposure. As pointed 
out above, communication of the actual substance concentrations identified is 
an important first step in understanding the environmental realities driving the 
identifications. Second, based on regulatory experience, if a cut-off is estab-
lished, it is important that this cut-off be communicated as an advisory to other 
jurisdictions. In this regard, it is difficult, from either a scientific or regulatory 
point of view, to understand the recent decision by the Oklahoma Horse Racing 
Commission to change its environmental exposure cut-off for methamphet-
amine from a published value to a confidential in-house one, thereby depriving 
the racing community of ready access to their best current regulatory wisdom 
concerning the need for an environmental cut-off for methamphetamine. HJ
IT’S POSSIBLE THAT ENVIRONMENTAL TRANSFER COULD OCCUR IN THE STARTING GATE FROM AN 
ASSISTANT STARTER TO A HORSE.
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